MEDERA Trademark

Blood bank services; Human tissue bank services; Organ and tissue bank services; Stem cell therapy services; Medical services; Consultancy in the field of the medical treatment and diagnosis of cardiovascular diseases

Bacteriological research for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Biological research for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Biomedical research services for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Chemical research for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Scientific research in the nature of conducting clinical trials for others; Conducting early evaluations for others in the field of new pharmaceuticals for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Development of biopharmaceutical preparations and medicines for gene and cell therapies for others for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Drug discovery services for others; Engineering services for others, particularly technical project planning and design engineering of lines for the processing of web products; Industrial research for others in the field of regenerative and reparative gene and cell therapies; Medical research laboratory services for others; Pharmaceutical research services for others; Pharmaceutical drug development services for others for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Pharmaceutical product evaluation for others; Providing medical and scientific research information for others in the field of pharmaceuticals and clinical trials; Research and development of new products for others; Research and development of vaccines and medicines for gene and cell therapies for others for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Scientific research for others in the field of gene therapy; Stem cell research services for others; Technical research for others in the field of pharmaceutical studies; Technology research for others in the field of regenerative gene and cell therapies